Quantcast

Latest Medicinal chemistry Stories

2014-04-02 04:21:27

KALAMAZOO, Mich., April 2, 2014 /PRNewswire/ -- Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter. The Peregrine System uses a unique, patent-pending technology to deliver diagnostic and therapeutic agents directly to the perivascular layer that surrounds blood vessels. This region is dynamic and consists of...

2014-04-01 23:32:49

Retail Management Solutions, a leader in pharmacy POS innovation, has released an e-book that covers how retailers are shifting from cash registers to mobile technology. The book is a must-read for anyone interested in pharmacy POS software. Lacey, WA (PRWEB) April 01, 2014 Retail Management Solutions (RMS), an industry leader in Pharmacy POS Innovation, today announced that they have officially launched their new e-book entitled “The Emergence of the Mobile Cash Register.” The...

2014-04-01 23:23:16

Professionals from across East Asia will discuss the latest hot topics in all stages of drug development at the 8th DIA Annual Conference in Japan for Asian New Drug Development. Tokyo, Japan (PRWEB) April 01, 2014 Professionals from across East Asia will discuss the latest hot topics in all stages of drug development at the 8th DIA Annual Conference in Japan for Asian New Drug Development. The event will return for its eighth year on May 22 to 23, at Sola City Hall, Ochanomizu in Tokyo....

2014-03-31 23:38:39

CDRH has recently overhauled its Office of Compliance — what exactly has changed and what hasn’t? In this exclusive question-and-answer webinar rebroadcast, FDA veteran Steve Niedelman, lead quality systems and compliance consultant to the FDA & Life Sciences practice team at King & Spalding, speaks with Steve Silverman, Director of CDRH’s Office of Compliance, to help device manufacturers understand all the changes. Falls Church, VA (PRWEB) March 31, 2014 CDRH’s Office...

2014-03-31 23:05:01

Dalton Medicinal Chemistry receives notice of renewal of award from NIDA of NIH to fund research of novel series of compounds to treat drug abuse and alleviate pain. Toronto, ON (PRWEB) March 31, 2014 Dalton Medicinal Chemistry has received notice that the award from the National Institute On Drug Abuse (NIDA) to research and discover a novel series of compounds with the potential to treat drug abuse and alleviate pain has been renewed. This work will be supported by NIDA of the National...

2014-03-31 16:26:42

BOSTON, March 31, 2014 /PRNewswire/ -- About six months ago, the United States Food and Drug Administration (FDA) released new rules which require most medical devices distributed in the United States to bear a Unique Device Identification, or a UDI. Debara Reese, Vice President, Quality and Compliance, for global life sciences compliance consulting firm, Maetrics, recently spoke at the BioMed Conference in Boston where she explained, "The most common pitfall I've seen regarding UDI...

2014-03-30 23:02:22

The Firm is actively evaluating GranuFlo recall lawsuits on behalf of individuals who allegedly suffered the deadly heart events associated with GranuFlo and NaturaLyte. New York, NY (PRWEB) March 30, 2014 Dialysis patients and families who may have been affected by the GranuFlo recall (http://www.thegranuflolawsuit.com/) are steadily filing claims in Massachusetts federal court over two medications allegedly tied to sudden cardiac death, heart attacks, strokes and other serious...

2014-03-27 23:02:53

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered sudden and catastrophic heart problems following the administration of GranuFlo or NaturaLyte Dialysis Concentrates. New York, NY (PRWEB) March 27, 2014 Hundreds of GranuFlo lawsuits (http://www.thegranuflolawsuit.com) filed in the wake of the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to move forward in courts throughout the country, Bernstein Liebhard LLP reports. According to...

2014-03-27 08:29:37

NEW YORK, March 27, 2014 /PRNewswire/ -- Across the globe, there are over 13 million new cancer cases each year. By 2030, it is estimated by the International Agency for Research on Cancer (IARC) that there will be approximately 21.4 million new cancer cases and 13.2 million cancer deaths worldwide. Some of the more common (and deadly) forms of cancer are head and neck cancer, which account for approximately 600,000 new cases worldwide each year and result in a five-year survival rate...

2014-03-26 23:33:00

The Corporate Whistleblower Center is strongly encouraging pharmaceutical industry insiders, or physicians to call them at 866-714-6466 if they possess substantial proof a drug company is knowingly off-labeling their pharmaceutical product as a way to increase profits, as pointed out in a recent Justice Department press release. The Whistleblower Center believes off-labeling puts patients at risk, and well documented proof of this type of activity can produce substantial whistleblower...


Latest Medicinal chemistry Reference Libraries

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.